United Therapeutics Corporation
United Therapeutics Corporation (UTHR) — Form 144: Proposed sale of shares
AI-generated summary
Officer PAUL MAHON of United Therapeutics Corporation proposed to sell 8,300 shares of Common stock with an aggregate market value of $4,968,932.78 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through a stock option exercise on November 5, 2026. The proposed sale is associated with a trading plan adopted on August 11, 2025.
Key facts
- Seller
- PAUL MAHON
- Relationship
- Officer
- Shares to sell
- 8,300
- Market value
- $4,968,932.78
- Approximate sale date
- Nov 5, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 5, 2026 · Stock Option Exercise
Rule 10b5-1 plan · adopted Aug 11, 2025
More UTHR filings
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
- SC 13G/A
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.